Literature DB >> 17276389

VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes.

Yao-Hua Song1, Sebastian Gehmert, Sanga Sadat, Kai Pinkernell, Xiaowen Bai, Nadine Matthias, Eckhard Alt.   

Abstract

Cardiomyocyte regeneration is limited in adult life and is not sufficient to compensate for cell loss with myocardial infarction. Hence, the identification of a useful source of cardiomyocyte progenitors is of great interest for possible use in regenerative therapy. In this study, we isolated stem cells derived from human subcutaneous adipose tissue. The expression of Nkx2.5 and GATA-4 can be observed by PCR directly after extraction and during cultivation in some of these cells. Cardiac Troponin T and myosin light chain-2v become positive after 12 days of cultivation. To define respective factors responsible for spontaneous differentiation, we measured VEGF level in ADSC conditioned medium. Our data showed that ADSC secrete significant amount of VEGF (283.5pg per microgram DNA) and that anti-VEGF receptor antibodies blocked the cardiac differentiation. In conclusion, we demonstrated the spontaneous differentiation of human subcutaneous adipose-derived stem cells into a cardiomyocyte phenotype under standard culturing conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276389     DOI: 10.1016/j.bbrc.2007.01.095

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

Review 1.  The potential of adipose stem cells in regenerative medicine.

Authors:  Bettina Lindroos; Riitta Suuronen; Susanna Miettinen
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

2.  Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.

Authors:  Jing Huang; Zhiping Zhang; Jian Guo; Aiguo Ni; Arjun Deb; Lunan Zhang; Maria Mirotsou; Richard E Pratt; Victor J Dzau
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

Review 3.  Adipose-derived stem cells for myocardial infarction.

Authors:  Manuel Mazo; Juan José Gavira; Beatriz Pelacho; Felipe Prosper
Journal:  J Cardiovasc Transl Res       Date:  2010-11-30       Impact factor: 4.132

Review 4.  Adipose-derived stem cells for regenerative medicine.

Authors:  Jeffrey M Gimble; Adam J Katz; Bruce A Bunnell
Journal:  Circ Res       Date:  2007-05-11       Impact factor: 17.367

5.  ADSCs differentiated into cardiomyocytes in cardiac microenvironment.

Authors:  Yanxia Zhu; Tianqing Liu; Kedong Song; Ruiming Ning; Xuehu Ma; Zhanfeng Cui
Journal:  Mol Cell Biochem       Date:  2008-12-24       Impact factor: 3.396

Review 6.  Adipose stem cells for bone tissue repair.

Authors:  Simone Ciuffi; Roberto Zonefrati; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

Review 7.  Key transcription factors in the differentiation of mesenchymal stem cells.

Authors:  Sami G Almalki; Devendra K Agrawal
Journal:  Differentiation       Date:  2016-03-21       Impact factor: 3.880

8.  Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair.

Authors:  David Zisa; Arsalan Shabbir; Gen Suzuki; Techung Lee
Journal:  Biochem Biophys Res Commun       Date:  2009-10-15       Impact factor: 3.575

Review 9.  Aesthetic cardiology: adipose-derived stem cells for myocardial repair.

Authors:  Nathan J Palpant; Joseph M Metzger
Journal:  Curr Stem Cell Res Ther       Date:  2010-06       Impact factor: 3.828

10.  Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo.

Authors:  Beatrice Cousin; Emmanuel Ravet; Sandrine Poglio; Fabienne De Toni; Mélanie Bertuzzi; Hubert Lulka; Ismahane Touil; Mireille André; Jean-Louis Grolleau; Jean-Marie Péron; Jean-Pierre Chavoin; Philippe Bourin; Luc Pénicaud; Louis Casteilla; Louis Buscail; Pierre Cordelier
Journal:  PLoS One       Date:  2009-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.